Latest / The 7investing Podcast
A CEO's Perspective of Investing in Biotechs with Al Altomari, CEO of Agile Therapeutics
Investing in general can be complicated. Investing in an industry one doesn’t understand well, and doing so successfully can be close to impossible. The biotech industry is like that for many people. The science in general can be confusing, and with scientific discovery, there are many unknowns. This makes investing in the industry even more challenging. 7investing Lead Advisor Dana Abramovitz talks about investing in biotechs with Agile Therapeutics CEO Al Altomari.
Agile Therapeutics is a commercialization stage biotech focused on women’s health. Listening to women and targeting unmet…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.